University of Louisville
B

Metabolic Targeting as a Therapeutic Strategy Against Endocrine Resistant HR+ Breast Cancer

By University of Louisville FEATURING Brian Clem
By University of Louisville FEATURING Brian Clem
52 views
September 27, 2024
Comments 0
Login to view comments. Click here to Login

Related Videos

21:34

The 2023 ASCO®/CAP Guideline Update on HER2 Testing/Classification: …

Shabnam Jaffer

674 views
12:42

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

191 views
05:58

New

ESMO 2024 Insights: Long-Term Outcomes and Treatment Strategies by E…

2024 ESMO Annual Meeting Insights Hub

K. Nozawa

86 views
11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood
11:31

Choosing Wisely for Young Women With Breast Cancer: Medical Therapy

ecancer

S. Subhash Kulkarni

47 views
03:02

Choosing Wisely for Young Women With Breast Cancer: Balco Medical Ce…

ecancer

S. Turkar

9 views
06:39

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

583 views
05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo
06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy
AUTOPLAY